Physician profile
Joseph A Lanzone
NPI 1073692174
$8,784.88
in general payments reported to CMS, 2019-2025
43 companies · $501 in 2025
The $501 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,718 · 2020: $799 · 2021: $1,427 · 2022: $615 · 2023: $1,745 · 2024: $979 · 2025: $501.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,703 · Travel and Lodging: $522.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,703.20 |
| Travel and Lodging | $521.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $2,057.55 | 2019-2020 | |
| Boston Scientific Corporation | $1,039.23 | 2019-2024 | Spaceoar Vue System - 10ml, Greenlight Xps, Lumenis Pulse 120h |
| Procept Biorobotics Corporation | $813.41 | 2019-2024 | Aquabeam Robotic System, Aquabeam System |
| Coloplast Corp | $617.07 | 2019-2025 | Speedicath, Titan |
| Astellas Pharma US INC | $604.41 | 2019-2025 | Xtandi |
| Myriad Genetic Laboratories, INC. | $428.94 | 2023-2024 | Prolaris |
| Teleflex LLC | $282.96 | 2021-2025 | Barrigel, Urolift |
| Janssen Biotech, INC. | $250.50 | 2019-2024 | Erleada, Akeega |
| Sumitomo Pharma America, INC. | $228.38 | 2023-2025 | Gemtesa, Orgovyx |
| Medtronic, INC. | $226.12 | 2021-2024 | Interstim, Nuro |
| Ferring Pharmaceuticals INC. | $217.91 | 2019-2025 | Adstiladrin |
| Endo Pharmaceuticals INC. | $202.29 | 2019-2023 | Xiaflex |
| Pfizer INC. | $186.89 | 2019-2025 | |
| Myovant Sciences INC. | $157.14 | 2021-2022 | |
| Medtronic USA, INC. | $148.93 | 2019-2020 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Lanzone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.